03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Aprovasc 300mg/5mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Manufacturer | Benta SAL |
Manufacturing Type | Packaging Under license from Sanofi Aventis Mexico SA |
Origin | Lebanon |
ATC | C09DB05 |
Revision Date | 01/02/2014 |
Aprovasc 300mg/5mg* :
Aprovasc 300mg/5mg* :
Aprovasc 300mg/5mg* :
Aprovasc 300mg/5mg* :
Aprovasc 300mg/5mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Aprovasc 300mg/5mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abdominal pain upper | Common |
Allergic reaction | Very rare |
Alopecia | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Arrhythmia | Very rare |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
Asthenia | Uncommon |
Atrial fibrillation | Very rare |
Azotemia prerenal | Uncommon |
Back pain | Uncommon |
Change of bowel habit | Uncommon |
Chest pain | Uncommon |
Cholestasis | Very rare |
Constipation | Uncommon |
Cough | Common |
Creatine increased | Uncommon |
Dermatitis contact | Common |
Diarrhoea (Diarrhea) | Uncommon |
Dizziness | Common |
Dry mouth (Xerostomia) | Uncommon |
Dyspepsia | Uncommon |
Dyspnoea (dyspnea) | Uncommon |
Erectile dysfunction | Uncommon |
Erythema multiforme | Very rare |
Face oedema | Common |
Fall | Uncommon |
Fatigue | Common |
Flushing | Common |
Function kidney decreased | Not known |
Gastritis | Very rare |
Gingival hyperplasia | Very rare |
Gingival swelling | Common |
Glossodynia | Common |
Gynecomastia (Gynaecomastia) | Uncommon |
Headache | Common |
Hepatic enzyme increased | Very rare |
Hepatitis | Very rare |
Hot flush | Common |
Hyperaesthesia | Uncommon |
Hyperglycaemia | Very rare |
Hyperkalaemia | Uncommon |
Hypersensitivity reactions | Not known |
Hypotension | Uncommon |
Impotence | Uncommon |
Insomnia | Uncommon |
Jaundice | Very rare |
Joint stiffness | Uncommon |
Liver function test abnormal | Not known |
Malaise | Uncommon |
Micturition disorder | Uncommon |
Mood alteration | Uncommon |
Muscle cramps | Uncommon |
Myalgia | Uncommon |
Myocardial infarction | Very rare |
Nausea | Common |
Nocturia | Uncommon |
Oedema | Uncommon |
Oedema peripheral | Common |
Orthostatic dizziness | Uncommon |
Orthostatic hypotension | Common |
Pain | Uncommon |
Palpitations | Common |
Pancreatitis | Very rare |
Paraesthesia (paresthesia) | Uncommon |
Peripheral neuropathy aggravated | Very rare |
Pollakiuria (Urinary frequency) | Uncommon |
Proteinuria | Common |
Pruritus | Uncommon |
Purpura | Uncommon |
Pyrosis (Heartburn) | Uncommon |
Renal failure | Very rare |
Rhinitis | Uncommon |
Sexual dysfunction | Uncommon |
Sinus bradycardia | Common |
Skin discolouration (Dyschromia) | Uncommon |
Skin rash | Uncommon |
Somnolence | Common |
Sweating increased (Excessive sweating) (Hyperhydrosis) | Uncommon |
Syncope | Uncommon |
Tachycardia | Uncommon |
Taste altered | Uncommon |
Thrombocytopenia (Thrombopenia) | Very rare |
Tinnitus | Uncommon |
Tongue disorder | Common |
Tremor | Uncommon |
Urticaria | Very rare |
Vasculitis | Very rare |
Ventricular tachycardia | Very rare |
Vertigo | Common |
Visual disturbance | Uncommon |
Vomiting | Common |
Weight decreased (Weight loss) | Uncommon |
Weight increased (weight gain) | Uncommon |
Aprovasc 300mg/5mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Aprovasc 300mg/5mg* MoH 7481 :
Form | Tablet, Film-Coated |
Packaging | Blisters |
Package Size | Box of 28 |
Strength | 5mg/300mg |
Storage Condition | <30°C Away from moisture |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 185945/13 |
Submission date | 01/01/2013 |
Registration Year | 2014 |
Archived Date | 02/03/2023 |
Barcode | 5283009051333 |
Price Comparison
● Country: | Tunisia | |
● Package Size: | Boîte de 28 | |
● Public Price: | 116 TND | ( 3,348,340.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 4,1429 TND | ( 115,460.00 LBP ) |
● Pricing Date: | 04/02/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 28 | |
● Public Price: | 135.95 SAR | ( 3,213,858.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 4,8554 SAR | ( 94,560.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | Boîte de 28 | |
● Public Price: | 13.19 KWD | ( 3,872,333.39 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,4711 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 11.14 KWD | ( 3270492.34 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | France |
● Package Size: | 28 |
● Medica Comments: | Not available in the country of origin |
● Reference: | ansm |
● Pricing Date: | 14/10/2019 |
● Type: | Medicine not available |
You have to register to view this info
Drop File